FDA approves Lilly’s Verzenio as adjuvant therapy for early breast cancer
Eli Lilly and Company (Lilly) has received the US Food and Drug Administration (FDA) approval for its Verzenio (abemaciclib) to treat a type of early breast cancer (EBC).
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XEli Lilly and Company (Lilly) has received the US Food and Drug Administration (FDA) approval for its Verzenio (abemaciclib) to treat a type of early breast cancer (EBC).
Merck has received the US Food and Drug Administration (FDA) approval for its anti-PD-1 therapy Keytruda, in combination with chemotherapy, to treat a type of cervical cancer. Keytruda
PCI Pharma Services (PCI) has agreed to acquire Lyophilization Services of New England (LSNE), a contract development and manufacturing organisation (CDMO) owned by private equity firm Permira. The
Biological E has filed an application with the Drugs Controller General of India (DCGI) seeking approval to conduct the Phase 3 study of its Covid-19 vaccine Corbevax. The
Merck has filed an application with the US Food and Drug Administration (FDA) seeking Emergency Use Authorisation (EUA) for its investigational oral antiviral molnupiravir. The submission indicates the
Roche’s subsidiary Genentech has received the US Food and Drug Administration (FDA) breakthrough therapy designation for its anti-amyloid beta antibody therapy Gantenerumab to treat Alzheimer’s disease (AD). Gantenerumab
ChemoCentryx has received the US Food and Drug Administration (FDA) approval for Tavneos (avacopan) to treat a type of vasculitis in adults, adjunct to standard therapy. The drug
Novartis’ biosimilars subsidiary Sandoz has completed the acquisition of GSK’s cephalosporin antibiotics business to strengthen its antibiotics capabilities. Through the acquisition, Sandoz obtains the rights to GSK’s three
The World Health Organization (WHO) has recommended the wide roll-out of malaria vaccine RTS,S/AS01 (RTS,S), among children in Africa and other regions with moderate to high malaria transmission.
Moderna is set to build a new manufacturing facility in Africa to produce up to 500 million doses of its mRNA-based vaccines annually, including its Covid-19 vaccine. The